Monika Wołosik, Natalia Bednarczyk, Rafał Bednarczyk, Radosław Krzysztof Binkowski, Agnieszka Kurek, Natalia Krajewska, Aleksandra Lejman, Aleksandra Mazurkiewicz, Hubert Sidor, Szymon Zysiak. COBENFY (XANOMELINE-TROSPIUM CHLORIDE) AS A BREAKTHROUGH IN SCHIZOPHRENIA TREATMENT: POTENTIAL IMPACT ON PATIENT QUALITY OF LIFE AND HEALTHCARE ECONOMICS. IJITSS [Internet]. 2026Jan.17 [cited 2026Feb.11];(1(49). Available from: https://rsglobal.pl/index.php/ijitss/article/view/4695